SEC Comment Letter 0000000000-23-004786 to PaxMedica, Inc. (PXMD) (CIK 0001811623)
PaxMedica, Inc. (PXMD) (CIK 0001811623)
Date: May 8, 2023 · CIK: 0001811623 · Accession: 0000000000-23-004786
AI Filing Summary & Sentiment
File numbers found in text: 333-271623
Letter
United States securities and exchange commission logo May 8, 2023 Howard J. Weisman Chief Executive Officer PaxMedica, Inc. 303 South Broadway, Suite 125 Tarrytown, NY 10591 Re:PaxMedica, Inc. Registration Statement on Form S-1 Filed May 4, 2023 File No. 333-271623 Dear Howard J. Weisman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tim Buchmiller at (202) 551-3635 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: David S. Rosenthal, Esq.
Show Raw Text
United States securities and exchange commission logo
May 8, 2023
Howard J. Weisman
Chief Executive Officer
PaxMedica, Inc.
303 South Broadway, Suite 125
Tarrytown, NY 10591
Re:PaxMedica, Inc.
Registration Statement on Form S-1
Filed May 4, 2023
File No. 333-271623
Dear Howard J. Weisman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Tim Buchmiller at (202) 551-3635 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: David S. Rosenthal, Esq.